This compound is a pharmaceutical intermediate featuring a pyridine ring substituted with a nitro group and protected by two tert-butoxycarbonyl (Boc) groups. It is primarily used as a building block in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(S)-3-Aminotetrahydrofuran tosylate
pharmaceutical intermediate
Cytidine, N-benzoyl-2'-deoxy-5-methyl-
pharmaceutical intermediate
N-Benzoyl-5'-O-(bis(4-methoxyphenyl)phenylmethyl)-2'-deoxy-5-methylcytidine
pharmaceutical intermediate
2-Hydroxy-3-methoxy-3,3-diphenylpropanoic Acid-d3 Methyl Ester
pharmaceutical intermediate
tert-butyl N-[(2-methylpropan-2-yl)oxycarbonyl]-N-(3-nitro-2-pyridinyl)carbamate
SDKVOBASBFCVML-UHFFFAOYSA-N
CC(C)(C)OC(=O)N(C1=C(C=CC=N1)[N+](=O)[O-])C(=O)OC(C)(C)C
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.